Free Trial

Moderna (MRNA) SEC Filings & 10K Form

Moderna logo
$24.56 -0.28 (-1.14%)
As of 09:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Moderna SEC Filings

DateFilerForm TypeView
09/02/2025
4:26 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025
4:20 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025
3:13 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025
3:06 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025
3:10 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2025
3:03 PM
Moderna (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2025
6:02 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
3:59 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
9:06 AM
Hussain Abbas (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
3:20 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:36 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
4:16 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:26 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
3:28 PM
Horning Sandra (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:47 AM
Moderna (Subject)
Form SCHEDULE 13G/A
04/30/2025
5:47 AM
BAILLIE GIFFORD & CO (Filed by)
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SCHEDULE 13G/A
04/07/2025
3:18 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:41 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:46 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:49 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:33 PM
Bancel Stephane (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
6:11 AM
Moderna (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
6:14 AM
Moderna (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
3:15 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:30 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:07 AM
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SCHEDULE 13G/A
01/13/2025
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:38 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
2:18 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
3:51 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:55 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
2:23 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:26 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:15 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:19 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
2:49 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:54 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:35 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
3:19 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
7:49 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
7:52 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRNA) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners